logo
Share SHARE
FONT-SIZE Plus   Neg

AstraZeneca: Lynparza Shows Improved Progression-free Survival Vs Chemotherapy

AstraZeneca (AZN.L) said, in the treatment of patients with HER2-negative metastatic breast cancer harbouring germline BRCA1 or BRCA2 mutations, Lynparza showed a statistically-significant and clinically-meaningful improvement in progression-free survival compared with those who received chemotherapy (capecitabine, vinorelbine or eribulin). Initial findings from this Phase III OLYMPIAD study indicate that the safety profile of Lynparza was consistent with previous studies.

OLYMPIAD is a randomised, multi-center Phase III trial assessing the efficacy and safety of Lynparza (300 mg twice daily) to 'physician's choice' chemotherapy in 302 patients with HER2-negative metastatic breast cancer with germline BRCA1 or BRCA2 mutations, which are predicted or suspected to be deleterious. The international study was conducted in 19 countries.

AstraZeneca said its Phase III OLYMPIAD trial was the first positive randomised trial to evaluate the efficacy and safety of a PARP inhibitor beyond ovarian cancer. A full evaluation of the OLYMPIAD data is ongoing and the results will be submitted for presentation at a forthcoming medical meeting.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Alphabet Inc. (GOOG, GOOGL), the parent company of Google, Thursday reported an increase in profit for the first quarter, driven largely revenue growth in search and advertising. Alphabet's first-quarter profit rose to $5.43 billion or $7.73 per share from $4.21 billion or $6.02 per share last year. On... A passenger was booted from a Delta Air Lines flight after an emergency run to the bathroom while the plane was delayed for almost two hours on the tarmac, according to media reports. Kima Hamilton, 39, reportedly said that he needed to use the restroom while the plane was on the tarmac in Atlanta en route to Milwaukee on April 18. McDonald's is going to discontinue a popular item that has been on the menu for decades - the Hi-C Orange Lavaburst - from May 1, according to a memo posted on Reditt. With customers having only a few more days to get their hands on the iconic, popular beverage before its gone forever, McDonald's is already facing a backlash for its decision.
comments powered by Disqus
Follow RTT